Genome Prairie

News Releases and Articles

Announcing New Interim President & CEO

March 25, 2020

Genome Prairie Announces Interim President & CEO Dr. Gerald Brown 

SASKATOON, March 25, 2020 – Genome Prairie announced today that Dr. Gerald Brown is assuming the position of interim President and CEO, effective immediately. Dr. Brown replaces Dr. Reno Pontarollo in this role. Genome Prairie’s Board of Directors is undertaking a search for a replacement.
 
Dr. Brown has served on Genome Prairie’s Board of Directors since 2005. He has more than 30 years of experience in agricultural biology, agronomy, intellectual property protection, and product development and commercialization.
 
In 1998, Dr. Brown joined the Saskatchewan Research Council as Director of its Business Development Branch and subsequently became Vice President of its Agriculture and Biotechnology Division. More recently, he was the Director of Marketing and Commercialization with the Pan-Provincial Vaccine Enterprise, a national Centre of Excellence for Commercialization and Research focused on the mid-stage development and commercialization of vaccines for infectious diseases.
           
The Board of Directors wishes to thank Dr. Pontarollo for his many years of service, his leadership and his contributions to the advancement of genomics and bioscience research in the provinces of Saskatchewan and Manitoba. 
 
More information on Genome Prairie, and its current research projects and competitions, can be found online at www.genomeprairie.ca.
                                                                           
About Genome Prairie
Genome Prairie, one of six independent Genome Canada centres, is a non-profit organization with offices in Saskatoon and Winnipeg. Genome Prairie develops and manages genomics and related bioscience research projects that address key regional priorities including agriculture, human health, the environment, energy and mining. These efforts play a central role in building the Prairie region’s reputation as a location of choice for innovation and commercialization.
                                                           
For more information, contact:

Beth Ireland
Director of Communications, Genome Prairie
306-713-0073
bireland@genomeprairie.ca